IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3037% above fair value
$82.31−1.14 (-1.37%)
Close on Nov 18, 2026Market cap $1.05BP/E 44.0Yield –
IRadimed free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
IRadimed's free cash flow for the twelve months ending Sep 30, 2026 was $26.14M, up 77.2% year over year. For fiscal 2025 it was $17.18M, down 2.5% from the year before. Over ten years it grew 8.9% a year on average. The highest annual figure on record is $17.62M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.18M | -2.5% |
| FY2024 | Dec 31, 2024 | $17.62M | +192.5% |
| FY2023 | Dec 31, 2023 | $6.02M | -34.7% |
| FY2022 | Dec 31, 2022 | $9.22M | -14.4% |
| FY2021 | Dec 31, 2021 | $10.78M | +100.5% |
| FY2020 | Dec 31, 2020 | $5.37M | -45.5% |
| FY2019 | Dec 31, 2019 | $9.86M | +38.0% |
| FY2018 | Dec 31, 2018 | $7.15M | +170.7% |
| FY2017 | Dec 31, 2017 | $2.64M | -69.4% |
| FY2016 | Dec 31, 2016 | $8.63M | +17.3% |
| FY2015 | Dec 31, 2015 | $7.35M | +267.2% |
| FY2014 | Dec 31, 2014 | $2.00M | +52.7% |
| FY2013 | Dec 31, 2013 | $1.31M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.87M | +17.4% |
| Q2 FY2026 | Jun 30, 2026 | $5.76M | +12.6% |
| Q1 FY2026 | Mar 31, 2026 | $7.89M | +1225.5% |
| Q4 FY2025 | Dec 31, 2025 | $5.63M | +76.1% |
| Q3 FY2025 | Sep 30, 2025 | $5.85M | +10.2% |
| Q2 FY2025 | Jun 30, 2025 | $5.11M | -7.1% |
| Q1 FY2025 | Mar 31, 2025 | $595.00K | -83.5% |
| Q4 FY2024 | Dec 31, 2024 | $3.20M | -5.4% |
| Q3 FY2024 | Sep 30, 2024 | $5.31M | +389.2% |
| Q2 FY2024 | Jun 30, 2024 | $5.50M | +66.3% |
| Q1 FY2024 | Mar 31, 2024 | $3.61M | – |
| Q4 FY2023 | Dec 31, 2023 | $3.38M | +21.6% |
| Q3 FY2023 | Sep 30, 2023 | $1.08M | -71.0% |
| Q2 FY2023 | Jun 30, 2023 | $3.31M | +128.1% |
| Q1 FY2023 | Mar 31, 2023 | -$1.75M | -240.8% |
| Q4 FY2022 | Dec 31, 2022 | $2.78M | -15.1% |
| Q3 FY2022 | Sep 30, 2022 | $3.75M | +16.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.45M | -58.1% |
| Q1 FY2022 | Mar 31, 2022 | $1.24M | +53.3% |
| Q4 FY2021 | Dec 31, 2021 | $3.28M | +36.3% |
| Q3 FY2021 | Sep 30, 2021 | $3.23M | +151.1% |
| Q2 FY2021 | Jun 30, 2021 | $3.46M | +427.3% |
| Q1 FY2021 | Mar 31, 2021 | $810.76K | -21.3% |
| Q4 FY2020 | Dec 31, 2020 | $2.40M | -36.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.29M | -58.0% |
| Q2 FY2020 | Jun 30, 2020 | $656.63K | -73.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.03M | +76.9% |
| Q4 FY2019 | Dec 31, 2019 | $3.78M | +9.0% |
| Q3 FY2019 | Sep 30, 2019 | $3.06M | +348.4% |
| Q2 FY2019 | Jun 30, 2019 | $2.44M | +68.1% |
| Q1 FY2019 | Mar 31, 2019 | $582.26K | -62.3% |
| Q4 FY2018 | Dec 31, 2018 | $3.46M | +170.9% |
| Q3 FY2018 | Sep 30, 2018 | $682.65K | -59.0% |
| Q2 FY2018 | Jun 30, 2018 | $1.45M | +1104.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.55M | – |
| Q4 FY2017 | Dec 31, 2017 | $1.28M | -35.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.67M | – |
| Q2 FY2017 | Jun 30, 2017 | $120.73K | – |
| Q1 FY2017 | Mar 31, 2017 | -$425.05K | – |
| Q4 FY2016 | Dec 31, 2016 | $1.99M | – |
See a number that looks wrong?